China Universal Asset Management Co. Ltd. cut its holdings in shares of CVS Health Corporation (NYSE: CVS) by 22.3% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,300 shares of the pharmacy operator's stock after selling 6,700 shares during the quarter. China

Stock News Zuckerberg testifies in youth harm case: Meta Platforms (META) CEO Mark Zuckerberg defended Instagram's design and policies in a Los Angeles trial ov

The Vanguard Short Term Corporate Bond ETF and the Vanguard Short Term Bond ETF are both designed for conservative investors. One focuses more on corporate bonds to offer higher income, while the other targets U.S. Treasuries for stability. This comparison explains how each option can affect your returns, helping you choose the one that best fits your goals.

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Investment aims to strengthen the pharmacy workforce and expand access to care across the state BATON ROUGE, La., Feb. 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced the launch of a new $5 million scholarship program designed to support aspiring pharmacists in the state of Louisiana.

Insights into Glenview Capital Management's Fourth Quarter 2025 Moves Larry Robbins (Trades, Portfolio) recently submitted the 13F filing for the fourth quarte

Insight into Mark Hillman (Trades, Portfolio)'s Fourth Quarter 2025 Investment Moves Mark Hillman (Trades, Portfolio) recently submitted the 13F filing for the

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Exploring the Latest 13F Filing and Investment Adjustments Introduction to Prem Watsa (Trades, Portfolio) Prem Watsa (Trades, Portfolio), a prominent figure in

Colrain Capital LLC raised its position in shares of CVS Health Corporation (NYSE: CVS) by 27.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 131,205 shares of the pharmacy operator's stock after purchasing an additional 27,863 shares during